Forest City | Science + Technology Group

The Region

Translational Research Lab at the
University of Pennsylvania

125 South 31st Street
Philadelphia, PA  19104

The University of Pennsylvania Medical School is one of the largest recipients of NIH grants

Photo: Seich + Ruffo Photography

The Translational Research Laboratory at U Penn is located in one of America's largest biotechnology clusters. The state of Pennsylvania was the one of the largest recipients of NIH grants in fiscal 2007, receiving almost $1.4 billion. Additionally the University of Pennsylvania Medical School was the second largest recipient of NIH grants, receiving more than $451 million in FY 2007.

Along with being one of the largest recipients of NIH grants, Pennsylvania offers many strengths that support the bioscience sector:

  • A location in the bio-pharma corridor - 80% of the world's largest pharmaceutical companies are within a 50-mile radius of Philadelphia - providing access to a deep scientific talent pool, exceptional managers and partners for the region's biotechnology companies
  • Close proximity to the world's financial center in New York City
  • Close proximity to the U.S. regulatory center in Washington, D.C.
  • One of the easiest springboard's in the U.S. to the European markets
  • Strong allied skills - ancillary industries and a robust service provider network that supports the growth of the industry.

Pennsylvania has also instituted innovative programs for the biosciences that include:

  • The Life Sciences Greenhouse Initiative, which provides a flexible mechanism for seed funding and the commercialization of biotechnology and other life sciences business opportunities by accelerating technology transfer, enhancing collaboration, and attracting new business
  • Keystone Innovation Zones, geographically-designated zones of opportunity and innovation, designed to harness resources made available through partnerships formed by a combination of institutions of higher education, private businesses, business support organizations, commercial lending institutions, and venture capital networks including angel investors and foundations
  • The Commonwealth Universal Research Enhancement (CURE) program, through which research grants are awarded to Pennsylvania healthcare institutions, colleges, universities and non-profit health organizations
  • Expanded R&D tax credits, with a tradability provision